Xylo Technologies (Xylo Technologies) Total Stockholders Equity : $23.58 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Xylo Technologies Total Stockholders Equity?

Xylo Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $23.58 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Xylo Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was $12.63. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Xylo Technologies's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.42.

Xylo Technologies Total Stockholders Equity Historical Data

The historical data trend for Xylo Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xylo Technologies Total Stockholders Equity Chart

Xylo Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

6.71

22.96

49.19

39.14

23.58

Xylo Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															49.19	45.14	39.14	31.76	23.58

Xylo Technologies (NAS:XYLO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Xylo Technologies's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(23.576	-	0)	/	1.86596
	=	12.63

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Xylo Technologies's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.084	+	0.702)	/	23.576
	=	0.42

Xylo Technologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Xylo Technologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Xylo Technologies (Xylo Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xylo Technologies Ltd (NAS:XYLO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

2QM0:Germany

Address

10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072

Website

https://www.medigus.com

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.